The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Resolvedstocks

FDA Reauthorizes Philip Morris IQOS as Modified Risk Tobacco Product

First Detected: Apr 17, 2026, 10:01 PM

Last Update: 3 months ago

10 articles·4 stories

Event Summary

On April 17, the U.S. FDA authorized the renewal of modified risk tobacco product (MRTP) orders for IQOS devices and HEETS consumables. This renewal allows Philip Morris to continue sharing reduced-exposure information with U.S. adults aged 21 and older who use traditional cigarettes.

Timeline

Philip Morris Raises 2026 Guidance Following 9.1% Revenue Growth in Q1

Apr 22, 2026, 11:30 AMImpact: 5

Institutional and Insider Stake Reductions in Philip Morris International

Apr 22, 2026, 9:15 AMImpact: 4

Philip Morris Cuts Annual Profit Forecast Despite FDA IQOS Status Renewal

Apr 20, 2026, 4:17 PMImpact: 4

FDA Reauthorizes Philip Morris IQOS as Modified Risk Tobacco Product

Apr 17, 2026, 10:01 PMImpact: 7

FDA Reauthorizes Philip Morris IQOS as Modified Risk Tobacco Product

Event Summary

Timeline

Price Impact